
pmid: 19659445
The NSAID class of medications is frequently used for mild to moderate pain. While overall safe, NSAIDs have several important adverse effects including esophageal, gastric and duodenal ulceration which limit their use. This has led to the development of NSAIDs with either less gastrointestinal side effects or concurrent use of medications to prevent NSAID gastrointestinal side effects. While several classes of medications exist for the prevention of gastrointestinal side effects, few combination treatments are available in a single pill. Towards this end, a combination pill of ibuprofen and famotidine (HZT-501, Horizon Therapeutics, Skokie, IL. USA) has been developed.
Drug Combinations, Clinical Trials, Phase III as Topic, Gastrointestinal Diseases, Anti-Inflammatory Agents, Non-Steroidal, Humans, Pain, Ibuprofen, Anti-Ulcer Agents, Famotidine
Drug Combinations, Clinical Trials, Phase III as Topic, Gastrointestinal Diseases, Anti-Inflammatory Agents, Non-Steroidal, Humans, Pain, Ibuprofen, Anti-Ulcer Agents, Famotidine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
